Behavioral effects of neuropeptides in rodent models of depression and anxiety

Depression: a new animal model sensitive to antidepressant treatments

PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · see citing works

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · see citing works

Characterization of a 41-Residue Ovine Hypothalamic Peptide that Stimulates Secretion of Corticotropin and β-Endorphin

Vale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904 · see citing works

Behavioural despair in rats: A new model sensitive to antidepressant treatments

Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138 · see citing works

Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress

Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · see citing works

Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant

Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993 · see citing works

The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice

Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674 · see citing works

Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639 · see citing works

Assessing antidepressant activity in rodents: recent developments and future needs

Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · see citing works

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

Vaughan, J. M., Donaldson, C. J., Bittencourt, J. C., Perrin, M. H., Lewis, K., Sutton, S. W., Chan, R. K. W., Turnbull, A. V., Lovejoy, D. A., RIVIER, C. L., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479 · see citing works

The role of corticotropin-releasing factor in depression and anxiety disorders

Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378 · see citing works

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352 · see citing works

A potent and selective endogenous agonist for the µ-opiate receptor

Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,309 · see citing works

Fear and anxiety: Animal models and human cognitive psychophysiology

Lang, P. J., Davis, M., & Öhman, A. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00343-8 · Cited by 1,162 · see citing works

Chronic mild stress-induced anhedonia: A realistic animal model of depression

Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · see citing works

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

Cryan, J. F., Valentino, R. J., & Lucki, I. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.008 · Cited by 1,115 · see citing works

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

Kramer, M. S., Cutler, N. R., Feighner, J. P., Shrivastava, R. K., Carman, J. S., Sramek, J. J., Reines, S. A., Liu, G. F., Snavely, D. B., Wyatt-Knowles, E. S., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071 · see citing works

Is the forced swimming test a suitable model for revealing antidepressant activity?

Borsini, F., & Meli, A. (1988) · Psychopharmacology · doi:10.1007/bf00176837 · Cited by 1,054 · see citing works

Anxiety, defence and the elevated plus-maze.

Rodgers, R., & Dalvi, A. (1997) · Neuroscience and Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00058-9 · Cited by 1,028 · see citing works

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925 · see citing works

Ethologically-based animal models of anxiety disorders.

Lister, R. (1990) · Pharmacology and Therapeutics · doi:10.1016/0163-7258(90)90021-s · Cited by 894 · see citing works

Urocortin II: A Member of the Corticotropin-Releasing Factor (CRF) Neuropeptide Family that Is Selectively Bound by Type 2 CRF Receptors

Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887 · see citing works

The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs

File, S. E. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90012-6 · Cited by 820 · see citing works

CAN SOCIAL INTERACTION BE USED TO MEASURE ANXIETY?

File, S. E., & Hyde, J. R. G. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb07001.x · Cited by 808 · see citing works

Brain oxytocin: A key regulator of emotional and social behaviours in both females and males

Neumann, I. D. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01726.x · Cited by 743 · see citing works

Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety

Shepherd, J. K., Grewal, S. S., Fletcher, A., Bill, D. J., & Dourish, C. T. (1994) · Psychopharmacology · doi:10.1007/bf02244871 · Cited by 739 · see citing works

Fear-potentiated startle: A neural and pharmacological analysis

Davis, M., Falls, W. A., Campeau, S., & Kim, M. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90102-v · Cited by 737 · see citing works

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

Zobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705 · see citing works

Anxiogenic stimuli in the elevated plus-maze

Treit, D., Menard, J., & Royan, C. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90492-c · Cited by 628 · see citing works

Neuropeptides — an overview

Hökfelt, T. G. M., Broberger, C., Xu, Q., Sergeyev, V., Ubink, R., & Diez, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00010-1 · Cited by 607 · see citing works

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

Beinfeld, M. C., Meyer, D., Eskay, R. L., Jensen, R. T., & Brownstein, M. (1981) · Brain Research · doi:10.1016/0006-8993(81)90031-7 · Cited by 551 · see citing works

Vasopressin: Behavioral roles of an “original” neuropeptide

Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504 · see citing works

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

Hughes, J. W., Boden, P., Costall, B., Domeney, A. M., Kelly, E., Horwell, D. C., Hunter, J. C., Pinnock, R. D., & Woodruff, G. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6728 · Cited by 501 · see citing works

Different data from different labs: Lessons from studies of gene–environment interaction

Wahłsten, D., Metten, P., Phillips, T. J., Boehm, S. L., Burkhart‐Kasch, S., Dorow, J. D., Doerksen, S., Downing, C., Fogarty, J., Rodd‐Henricks, K., et al. (2002) · Journal of Neurobiology · doi:10.1002/neu.10173 · Cited by 495 · see citing works

Animal model of depression: Pharmacological sensitivity of a hedonic deficit

Katz, R. J. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90053-3 · Cited by 480 · see citing works

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092012099 · Cited by 471 · see citing works

Brain Oxytocin Inhibits Basal and Stress‐Induced Activity of the Hypothalamo‐Pituitary‐Adrenal Axis in Male and Female Rats: Partial Action Within the Paraventricular Nucleus

Neumann, Wigger, Torner, Holsboer, & Landgraf (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00442.x · Cited by 452 · see citing works

Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2

Radulovic, J., Rühmann, A., Liepold, T., & Spiess, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05016.1999 · Cited by 402 · see citing works

Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats

Neumann, I. D., Torner, L., & Wigger, A. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00433-9 · Cited by 402 · see citing works

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

Holmes, A., Heilig, M. A., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 401 · see citing works

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

Heilig, M. A., S�derpalm, B., Engel, J. A., & Widerl�v, E. (1989) · Psychopharmacology · doi:10.1007/bf00441953 · Cited by 390 · see citing works

Central CRH system in depression and anxiety — Evidence from clinical studies with CRH1 receptor antagonists

Holsboer, F., & Ising, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.032 · Cited by 380 · see citing works

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

Schulz, D. W., Mansbach, R. S., Sprouse, J. S., Braselton, J. P., Collins, J. L., Corman, M. L., Dunaiskis, A. R., Faraci, S., Schmidt, A. W., Seeger, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10477 · Cited by 377 · see citing works

The Flinders sensitive line rats: a genetic animal model of depression

Overstreet, D. H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80230-1 · Cited by 369 · see citing works

A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder

Guastella, A. J., Howard, A. L., Dadds, M. R., Mitchell, P., & Carson, D. S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.01.005 · Cited by 366 · see citing works

Neuropeptides: opportunities for drug discovery

Hökfelt, T. G. M., Bartfai, T., & Bloom, F. E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00482-4 · Cited by 333 · see citing works

An Anxiolytic Action of Oxytocin is Enhanced by Estrogen in the Mouse

MCCARTHY, M. M., MCDONALD, C. H., BROOKS, P. J., & GOLDMAN, D. (1996) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00212-0 · Cited by 328 · see citing works

Plasma oxytocin levels and anxiety in patients with major depression

Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Maréchal, P., Péqueux, C., Ansseau, M., & Legros, J. J. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.01.009 · Cited by 325 · see citing works

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

Ring, R. H., Malberg, J. E., Potestio, L., Ping, J., Boikess, S., Luo, B., Schechter, L. E., Rizzo, S., Rahman, Z., & Rosenzweig-Lipson, S. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0293-z · Cited by 319 · see citing works

Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression

van Londen, L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00054-7 · Cited by 306 · see citing works

The role of substance P in stress and anxiety responses

Ebner, K., & Singewald, N. (2006) · Amino Acids · doi:10.1007/s00726-006-0335-9 · Cited by 304 · see citing works

The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic

Blanchard, D. C., Griebel, G., & Blanchard, R. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01276-7 · Cited by 295 · see citing works

Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

Keller, M., Montgomery, S., Ball, W., Morrison, M., Snavely, D., Liu, G., Hargreaves, R., Hietala, J., Lines, C., Beebe, K., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.013 · Cited by 286 · see citing works

Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin

Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., & Koenig, J. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.042 · Cited by 270 · see citing works

Diazepam and flurazepam: Effects on conditioned fear as measured with the potentiated startle paradigm

Davis, M. (1979) · Psychopharmacology · doi:10.1007/bf00426027 · Cited by 263 · see citing works

Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin

Wigger, A., Sánchez, M. M., Mathys, K. C., Ebner, K., Frank, E., Liu, D., Kresse, A. E., Neumann, I. D., Holsboer, F., Plotsky, P. M., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300290 · Cited by 263 · see citing works

Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

Kramer, M. S., Winokur, A., Kelsey, J. E., Preskorn, S., Rothschild, A. J., Snavely, D. B., Ghosh, K., Ball, W. A., Reines, S. A., Munjack, D. J., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300260 · Cited by 254 · see citing works

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH ₁ Antagonist) in the Treatment of Major Depression

Binneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254 · see citing works

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress**This research was supported by NIMH Grant MH-50479 and the Undergraduate Research Opportunities Program at the University of Colorado at Boulder.

Deak, T., Nguyen, K. T., Ehrlich, A. L., Watkins, L. R., Spencer, R. L., Maier, S. F., Licinio, J., Wong, M.-L., Chrousos, G. P., Webster, E., et al. (1999) · Endocrinology · doi:10.1210/endo.140.1.6415 · Cited by 242 · see citing works

Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats

Ebner, K., Rupniak, N. M. J., Saria, A., & Singewald, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400794101 · Cited by 225 · see citing works

Isolation and structure of hypothalamic MSH release-inhibiting hormone

Nair, R. M. G., Kastin, A. J., & Schally, A. V. (1971) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(71)80026-8 · Cited by 224 · see citing works

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

Singh, L., Lewis, A. S., Field, M. J., Hughes, J. W., & Woodruff, G. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1130 · Cited by 213 · see citing works

Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin

Becker, C., Zeau, B., Rivat, C., Blugeot, A., Hamon, M., & Benoliel, J. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002097 · Cited by 211 · see citing works

The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test

Redrobe, J. P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00403-1 · Cited by 207 · see citing works

Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats.

Takahashi, L. K., Kalin, N. H., Burgt, J. A. V., & Sherman, J. E. (1989) · Behavioral Neuroscience · doi:10.1037//0735-7044.103.3.648 · Cited by 203 · see citing works

Oxytocin acts as an antidepressant in two animal models of depression

Arletti, R., & Bertolini, A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90600-x · Cited by 203 · see citing works

Social Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by Oxytocin

Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., & Koenig, J. I. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300722 · Cited by 199 · see citing works

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures

Broqua, P., Wettstein, J. G., Rocher, M. N., Gauthier-Martin, B., & Junien, J. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199504000-00001 · Cited by 198 · see citing works

Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats

Slattery, D. A., & Neumann, I. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.038 · Cited by 195 · see citing works

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist

Mansbach, R. S., Brooks, E. N., & Chen, Y. L. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00025-3 · Cited by 195 · see citing works

Pharmacological characterization of Endomorphin-1 and Endomorphin-2 in Mouse Brain

Goldberg, I. E., Rossi, G. C., Letchworth, S. R., Mathis, J. P., Ryan‐Moro, J. P., Leventhal, L., Su, W., Emmel, D. W., Bolan, E. A., & Pasternak, G. W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37681-5 · Cited by 189 · see citing works

Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal 3 ) antagonists SNAP 37889 and SNAP 398299

Swanson, C. J., Blackburn, T. P., Zhang, X., Zheng, K., Xu, Q., Hökfelt, T. G. M., Wolinsky, T. D., Konkel, M. J., Chen, H., Zhong, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508970102 · Cited by 182 · see citing works

Regulation of Formation and Proposed Structure of the Factor Inhibiting the Release of Melanocyte-Stimulating Hormone

Celis, M. E., Taleisnik, S., & Walter, R. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.7.1428 · Cited by 181 · see citing works

Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats.

Takahashi, L. K., Kalin, N. H., Burgt, J. A. V., et al. (1989) · Behavioral Neuroscience · doi:10.1037/0735-7044.103.3.648 · Cited by 175 · see citing works

Septal vasopressin modulates anxiety-related behaviour in rats

Liebsch, G., Wotjak, C. T., Landgraf, R., & Engelmann, M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13069-x · Cited by 173 · see citing works

Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders?

Griebel, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00041-2 · Cited by 171 · see citing works

Central Oxytocin Administration Reduces Stress-Induced Corticosterone Release and Anxiety Behavior in Rats¹

Windle, R. J., Shanks, N., Lightman, S. L., & Ingram, C. D. (1997) · Endocrinology · doi:10.1210/en.138.7.2829 · Cited by 170 · see citing works

Urocortin, a novel neuropeptide with anxiogenic-like properties

Moreau, J., Kilpatrick, G. J., & Jenck, F. (1997) · Neuroreport · doi:10.1097/00001756-199705060-00027 · Cited by 170 · see citing works

Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics

Mathew, S. J., Price, R. B., & Charney, D. S. (2008) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30172 · Cited by 168 · see citing works

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice

Teixeira, R. M., Santos, A. R. S., Ribeiro, S. J., Calixto, J. Β., Rae, G. A., & de Lima, T. C. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00390-1 · Cited by 166 · see citing works

Localization of oxytocin receptor messenger ribonucleic acid in the rat brain.

Yoshimura, R., Kiyama, H., Kimura, T., Araki, T., Maeno, H., Tanizawa, O., & Tohyama, M. (1993) · Endocrinology · doi:10.1210/endo.133.3.8396014 · Cited by 161 · see citing works

The Role of CRF in Behavioral Aspects of Stress

Heinrichs, S. C., Menzaghi, F., Pich, E. M., Britton, K. T., & Koob, G. F. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44673.x · Cited by 160 · see citing works

The vasopressin system — From antidiuresis to psychopathology

Frank, E., & Landgraf, R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.063 · Cited by 159 · see citing works

Long-term neuroendocrine and behavioural effects of a single exposure to stress in adult animals

Armario, A., Escorihuela, R. M., & Nadal, R. A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.04.003 · Cited by 155 · see citing works

The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats

Keck, M. E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F., & Landgraf, R. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01383.x · Cited by 154 · see citing works

Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001

Okuyama, S., Chaki, S., Kawashima, N., Suzuki, Y., Ogawa, S., Nakazato, A., Kumagai, T., Okubo, T., & Tomisawa, K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38220-5 · Cited by 152 · see citing works

Galanin – 25 years with a multitalented neuropeptide

Mitsukawa, K., Lü, X., & Bartfai, T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8153-8 · Cited by 151 · see citing works

The Vogel conflict test: procedural aspects, γ-aminobutyric acid, glutamate and monoamines

Millan, M. J., & Brocco, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01275-5 · Cited by 149 · see citing works

Differential modulation of lateral septal vasopressin receptor blockade in spatial learning, social recognition, and anxiety-related behaviors in rats

Everts, H. G. J., & Koolhaas, J. M. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00004-7 · Cited by 148 · see citing works

Brain Penetrance, Receptor Occupancy and Antistress In Vivo Efficacy of a Small Molecule Corticotropin Releasing Factor Type I Receptor Selective Antagonist

Heinrichs, S. C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00299-3 · Cited by 148 · see citing works

The role of CRH in behavioral responses to stress

Smagin, G. N., Heinrichs, S. C., & Dunn, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00384-9 · Cited by 148 · see citing works

The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by Stress

Henry, B., Vale, W., & Markou, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1494-06.2006 · Cited by 147 · see citing works

Neuropeptide Y in the Amygdala Induces Long-Term Resilience to Stress-Induced Reductions in Social Responses But Not Hypothalamic–Adrenal–Pituitary Axis Activity or Hyperthermia

Sajdyk, T. J., Johnson, P. L., Leitermann, R. J., Fitz, S. D., Dietrich, A. D., Morin, M., Gehlert, D. R., Urban, J. H., & Shekhar, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0659-07.2008 · Cited by 147 · see citing works

Neuropeptide Y (NPY) and depression: From animal studies to the human condition

Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02159-8 · Cited by 146 · see citing works

Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats

Stogner, K. A., & Holmes, P. V. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00800-6 · Cited by 144 · see citing works

Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist

Ring, R. H., Schechter, L. E., Leonard, S. K., Dwyer, J. M., Platt, B. J., Graf, R., Grauer, S. M., Pulicicchio, C. M., Resnick, L., Rahman, Z. U., et al. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.016 · Cited by 144 · see citing works

Biological actions of galanin

Crawley, J. N. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00083-n · Cited by 143 · see citing works

Anti-Stress Action of a Corticotropin-Releasing Factor Antagonist on Behavioral Reactivity to Stressors of Varying Type and Intensity

Heinrichs, S. C., Menzaghi, F., Pich, E. M., Baldwin, H. A., Rassnick, S., Britton, K. T., & Koob, G. F. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380104 · Cited by 143 · see citing works

Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

Valdez, G. R., Inoue, K., Koob, G. F., Rivier, J., Vale, W., & Zorrilla, E. P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02707-5 · Cited by 143 · see citing works

Differences in intermale aggression are accompanied by opposite vasopressin release patterns within the septum in rats bred for low and high anxiety

Beiderbeck, D. I., Neumann, I. D., & Veenema, A. H. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05974.x · Cited by 142 · see citing works

Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist

Valdez, G. R., Zorrilla, E. P., Rivier, J., Vale, W., & Koob, G. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02971-8 · Cited by 140 · see citing works

Galanin: A Significant Role in Depression?

Weiss, J. M., Bonsall, R. W., Demetrikopoulos, M. K., Emery, M., & West, C. H. K. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10707.x · Cited by 140 · see citing works

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

Kunzel, H. E., Zobel, A. W., Nickel, T., Ackl, N., Uhr, M., Sonntag, A., Ising, M., & Holsboer, F. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00070-0 · Cited by 134 · see citing works

Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety

Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132 · see citing works

A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus

Lü, X., Barr, A. M., Kinney, J. W., Sanna, P. P., Conti, B., Behrens, M. M., & Bartfai, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408891102 · Cited by 131 · see citing works

Behavioral reactivity to stress

Khoshbouei, H., Cecchi, M., Dove, S., Javors, M. A., & Morilak, D. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00683-9 · Cited by 130 · see citing works

Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation

Sørensen, G., Lindberg, C., Wörtwein, G., Bolwig, T. G., & Woldbye, D. P. D. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20200 · Cited by 124 · see citing works

Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test

Heilig, M. A., McLeod, S., Koob, G. K., & Britton, K. T. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90514-u · Cited by 123 · see citing works

Behavioral Characteristics of Rat Lines Selected for Differential Hypothermic Responses to Cholinergic or Serotonergic Agonists

Overstreet, D. H. (2002) · Behavior Genetics · doi:10.1023/a:1020262205227 · Cited by 122 · see citing works

Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models

Rotzinger, S., & Vaccarino, F. J. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0322 · Cited by 120 · see citing works

The Gerbil Elevated Plus-maze II Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists

Varty, G. B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00313-5 · Cited by 120 · see citing works

Neuropeptide Y Produces Anxiety Via Y2-Type Receptors

Nakajima, M., Inui, A., Asakawa, A., Momose, K., Ueno, N., Teranishi, A., Baba, S., & Kasuga, M. (1998) · Peptides · doi:10.1016/s0196-9781(97)00298-2 · Cited by 119 · see citing works

Differential Role of Galanin Receptors in the Regulation of Depression-Like Behavior and Monoamine/Stress-Related Genes at the Cell Body Level

Kuteeva, E., Wardi, T., Lundström, L., Sollenberg, U. E., Langel, Ü., Hökfelt, T., & Ögren, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301660 · Cited by 117 · see citing works

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

Kramer, M. S., Cutler, N. R., Ballenger, J. C., Patterson, W. M., Mendels, J., Chenault, A., Shrivastava, R. K., Matzura‐Wolfe, D., Lines, C., & Reines, S. A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00190-e · Cited by 117 · see citing works

The behavioural effects of corticotropin-releasing factor-related peptides in rats

Jones, D. N. C., Kortekaas, R., Slade, P. D., Middlemiss, D. N., & Hagan, J. J. (1998) · Psychopharmacology · doi:10.1007/s002130050654 · Cited by 115 · see citing works

The role of Corticotropin Releasing Factor in Depressive Illness: a Critical Review

Mitchell, A. J. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00059-6 · Cited by 115 · see citing works

Anxiolytic-like action of centrally administered galanin

Bing, O., Møller, C. H., Engel, J. A., Söderpalm, B., & Heilig, M. A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90846-d · Cited by 114 · see citing works

Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression

Overstreet, D. H., & Griebel, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.035 · Cited by 112 · see citing works

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415

Stemmelin, J., Lukovic, L., Salome, N., & Griebel, G. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300562 · Cited by 112 · see citing works

Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis.

Burbach, J. P. H., & Lebouille, J. L. M. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33011-4 · Cited by 111 · see citing works

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor

Gehlert, D. R., Shekhar, A., Morin, S. M., Hipskind, P. A., Zink, C., Gackenheimer, S. L., Shaw, J., Fitz, S. D., & Sajdyk, T. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.030 · Cited by 110 · see citing works

Anxiogenic-Like Action of Galanin after Intra-Amygdala Administration in the Rat

Möller, C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00102-x · Cited by 110 · see citing works

Galanin and Its Receptors in Neurological Disorders

Lundström, L., Elmquist, A., Bartfai, T., & Langel, Ü. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:157 · Cited by 110 · see citing works

Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice

Risbrough, V. B., Hauger, R. L., Pelleymounter, M. A., & Geyer, M. A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1535-6 · Cited by 107 · see citing works

A water lick conflict paradigm using drug experienced rats

Petersen, E. N., & Lassen, J. B. (1981) · Psychopharmacology · doi:10.1007/bf00432430 · Cited by 104 · see citing works

Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression

Overstreet, D. H., Keeney, A. J., & Hogg, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.010 · Cited by 104 · see citing works

Galanin, Galanin Receptor Subtypes and Depression-Like Behaviour

Kuteeva, E., Hökfelt, T. G. M., Wardi, T., & Ögren, S. O. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_12 · Cited by 102 · see citing works

Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice

Karlsson, R., Holmes, A., Heilig, M. A., & Crawley, J. N. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.12.009 · Cited by 102 · see citing works

Melanocyte-Stimulating Hormone-Release Inhibiting Hormone as an Antidepressant

Ehrensing, R. H. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760070047007 · Cited by 96 · see citing works

Galanin receptors: Involvement in feeding, pain, depression and Alzheimer's disease

Kask, K., Berthold, M., & Bartfai, T. (1997) · Life Sciences · doi:10.1016/s0024-3205(96)00624-8 · Cited by 94 · see citing works

Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695 A Comparison to Other Classes of Anxiolytic Agent

Millan, M. J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00244-5 · Cited by 94 · see citing works

Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze

Britton, K. T., Akwa, Y., Spina, M. G., & Koob, G. F. (2000) · Peptides · doi:10.1016/s0196-9781(99)00169-2 · Cited by 94 · see citing works

Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm

Kehne, J. H., Cassella, J. V., & Davis, M. (1988) · Psychopharmacology · doi:10.1007/bf00735872 · Cited by 93 · see citing works

Urocortin and the brain

Pan, W., & Kastin, A. J. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.008 · Cited by 92 · see citing works

Escape deficits induced by uncontrollable stress: Antagonism by dopamine and norepinephrine agonists

Anisman, H., Suissa, A., & Sklar, L. S. (1980) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(80)93132-5 · Cited by 92 · see citing works

On the role of urocortin 1 in the non-preganglionic Edinger–Westphal nucleus in stress adaptation

Kozicz, T. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.04.005 · Cited by 92 · see citing works

Galanin – 25 years with a multitalented neuropeptide

Kuteeva, E., Hökfelt, T. G. M., Wardi, T., & Ögren, S. O. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8160-9 · Cited by 92 · see citing works

Vasopressin administration modulates anxiety-related behavior in rats

Appenrodt, E., Schnabel, R., & Schwarzberg, H. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00119-x · Cited by 91 · see citing works

Enkephalin and other peptides reduce passiveness

Kastin, A. J., Scollan, E. L., Ehrensing, R. H., Schally, A. V., & Coy, D. H. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90051-5 · Cited by 91 · see citing works

Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats

Wang, H., Wong, P. T. ‐., Spiess, J., & Zhu, Y. Z. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.05.008 · Cited by 89 · see citing works

Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats

Salomé, N., Stemmelin, J., Cohen, C., & Griebel, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0424-1 · Cited by 89 · see citing works

Modulatory Effects of Galanin in the Lateral Bed Nucleus of the Stria Terminalis on Behavioral and Neuroendocrine Responses to Acute Stress

Khoshbouei, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00424-9 · Cited by 88 · see citing works

Endomorphins have orexigenic and anxiolytic activities in mice

Asakawa, A., Inui, A., Momose, K., Ueno, N., Fujino, M., & Kasuga, M. (1998) · Neuroreport · doi:10.1097/00001756-199807130-00022 · Cited by 87 · see citing works

A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics

Treit, D. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90151-7 · Cited by 86 · see citing works

Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression

Rh, E., & Aj, K. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.5.562 · Cited by 86 · see citing works

Distribution of cholecystokinin (CCK) in the rat lower brain stem nuclei

Beinfeld, M. C., & Palkovits, M. (1982) · Brain Research · doi:10.1016/0006-8993(82)90794-6 · Cited by 85 · see citing works

Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin‐releasing factor receptor type 1 and type 2 agonists

de Groote, L., Peñalva, R. G., Flachskamm, C., Reul, J. M. H. M., & Linthorst, A. C. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03164.x · Cited by 84 · see citing works

Teneurin proteins possess a carboxy terminal sequence with neuromodulatory activity

Wang, L., Rotzinger, S., Chawaf, A. A., Elias, C. F., Baršytė-Lovejoy, D., Qian, X., Wang, N.-C., Cristofaro, A. D., Belsham, D. D., Bittencourt, J. C., et al. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.019 · Cited by 83 · see citing works

Subtype-Selective Corticotropin-Releasing Factor Receptor Agonists Exert Contrasting, but Not Opposite, Effects on Anxiety-Related Behavior in Rats

Zhao, Y., Valdez, G. R., Fekete, É. M., Rivier, J., Vale, W. W., Rice, K. C., Weiss, F., & Zorrilla, E. P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123208 · Cited by 83 · see citing works

Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression

Hodgson, R. A., Higgins, G. A., Guthrie, D. H., Lu, S. X., Pond, A. J., Mullins, D. E., Guzzi, M. F., Parker, E. M., & Varty, G. B. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.021 · Cited by 82 · see citing works

Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety

Rezayat, M., Roohbakhsh, A., Zarrindast, M.-R., Massoudi, R., & Djahanguiri, B. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.03.002 · Cited by 82 · see citing works

The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats

Papp, M., Vassout, A., & Gentsch, C. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00230-8 · Cited by 81 · see citing works

Activation of Amygdala CholecystokininBReceptors Potentiates the Acoustic Startle Response in the Rat

Frankland, P. W., Josselyn, S. A., Bradwejn, J., Vaccarino, F. J., & Yeomans, J. S. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01838.1997 · Cited by 81 · see citing works

Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice

Nielsen, D. M., Carey, G. J., & Gold, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.091 · Cited by 80 · see citing works

Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats

Krase, W., Koch, M., & Schnitzler, H. (1994) · Behavioural Brain Research · doi:10.1016/0166-4328(94)90053-1 · Cited by 79 · see citing works

Anxiolytic-like effect of the selective Neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze

Bacchi, F., Mathé, A. A., Jiménez, P., Stasi, L. P., Arban, R., Gerrard, P. A., & Caberlotto, L. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.020 · Cited by 79 · see citing works

A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder

Adams, J. B., Pyke, R. E., Costa, J., Cutler, N. R., Schweizer, E. E., Wilcox, C. S., Wisselink, P., Greiner, M., Pierce, M., & Pande, A. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199512000-00007 · Cited by 79 · see citing works

The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats

Shimazaki, T., Iijima, M., & Chaki, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.032 · Cited by 78 · see citing works

Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats

Kokare, D. M., Dandekar, M. P., Chopde, C. T., & Subhedar, N. K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.038 · Cited by 77 · see citing works

Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons

Spiga, F., Lightman, S. L., Shekhar, A., & Lowry, C. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.051 · Cited by 75 · see citing works

The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients

van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., Slaap, B. R., Radhakishun, F. S., & Pande, A. C. (1997) · Psychopharmacology · doi:10.1007/s002130050186 · Cited by 75 · see citing works

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

Griebel, G., Simiand, J., Stemmelin, J., Gal, C., & Steinberg, R. (2003) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007033482850 · Cited by 74 · see citing works

‘Anxiolytic’ effect of CCK-antagonists on plus-maze behavior in mice

Rataud, J., Darche, F., Piot, O., Stutzmann, J. M., Böhme, G. A., & Blanchard, J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91139-r · Cited by 73 · see citing works

Ultrasonic vocalizations in rat pups: modulation at the gamma-aminobutyric acidA receptor complex and the neurosteroid recognition site.

Vivian, J. A., Barros, H. M. T., Manitiu, A., & Miczek, K. A. (1997) · PubMed · Cited by 71 · see citing works

Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior

Bleickardt, C. J., Mullins, D. E., MacSweeney, C. P., Werner, B. J., Pond, A. J., Guzzi, M. F., Martin, F. D. C., Varty, G. B., & Hodgson, R. A. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1354-x · Cited by 71 · see citing works

Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat

Dableh, L. J., Yashpal, K., Rochford, J. M., & Henry, J. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.024 · Cited by 71 · see citing works

NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats

File, S. E. (2000) · Psychopharmacology · doi:10.1007/s002130000513 · Cited by 70 · see citing works

Galanin Receptor Antagonists

Ögren, S. O., Kuteeva, E., kfelt, T. H., & Kehr, J. (2006) · CNS Drugs · doi:10.2165/00023210-200620080-00003 · Cited by 68 · see citing works

Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.

Kask, A., Rägo, L., & Harro, J. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00076-7 · Cited by 67 · see citing works

A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests

Barr, A. M., Kinney, J. W., Hill, M. N., Lü, X., Biros, S. M., REBEK, J. J., & Bartfai, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.06.033 · Cited by 67 · see citing works

Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant‐like effect via Y1 receptor

Ishida, H., Shirayama, Y., Iwata, M., Katayama, S., Yamamoto, A., Kawahara, R., & Nakagome, K. (2007) · Hippocampus · doi:10.1002/hipo.20264 · Cited by 67 · see citing works

Cloning and characterization of teneurin C-terminus associated peptide (TCAP)-3 from the hypothalamus of an adult rainbow trout (Oncorhynchus mykiss)

Qian, X., Baršytė-Lovejoy, D., Wang, L., Chewpoy, B., Gautam, N., Chawaf, A. A., & Lovejoy, D. A. (2004) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2004.02.007 · Cited by 64 · see citing works

Galanin – 25 years with a multitalented neuropeptide

Hökfelt, T. G. M., & Tatemoto, K. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8152-9 · Cited by 62 · see citing works

Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect

Fendt, M., Bürki, H., Imobersteg, S., Lingenhöhl, K., McAllister, K. H., Orain, D., Uzunov, D. P., & Chaperon, F. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1610-8 · Cited by 61 · see citing works

Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.

Yamano, M., Yuki, H., Yasuda, S., & Miyata, K. (2000) · PubMed · Cited by 58 · see citing works

Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist

Ballard, T. M., Sänger, S., & Higgins, G. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00724-5 · Cited by 58 · see citing works

Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat

Overstreet, D. H., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.021 · Cited by 58 · see citing works

Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat

Kuteeva, E., Wardi, T., Hökfelt, T. G. M., & Ögren, S. O. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.003 · Cited by 57 · see citing works

Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon

Rajarao, S. J. R., Platt, B. J., Rizzo, S. J. S., Lin, Q., Bender, C. N., Nieuwenhuijsen, B. W., Ring, R. H., Schechter, L. E., Rosenzweig-Lipson, S. J., & Beyer, C. E. (2007) · Neuropeptides · doi:10.1016/j.npep.2007.05.001 · Cited by 56 · see citing works

Teneurin C-terminal associated peptides: An enigmatic family of neuropeptides with structural similarity to the corticotropin-releasing factor and calcitonin families of peptides

Lovejoy, D. A., Chawaf, A. A., & Cadinouche, M. Z. A. (2006) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2006.01.012 · Cited by 56 · see citing works

The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice

Hernando, F., Fuentes, J., Roques, B. P., & Ruiz‐Gayo, M. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90115-5 · Cited by 55 · see citing works

Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?

Mathé, A. A., Husum, H., Khoury, A. E., Jiménez-Vasquez, P. A., Gruber, S. H. M., Wörtwein, G., Nikisch, G., Baumann, P., Ågren, H., Andersson, W., et al. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.016 · Cited by 55 · see citing works

Regulation of neurite growth in immortalized mouse hypothalamic neurons and rat hippocampal primary cultures by teneurin C-terminal-associated peptide-1

Chawaf, A. A., Amant, K. S., Belsham, D. D., & Lovejoy, D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.062 · Cited by 54 · see citing works

Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder

Pande, A. C., Greiner, M., Adams, J. B., Lydiard, R. B., & Pierce, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00090-6 · Cited by 54 · see citing works

Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats

Cassella, J. V., & Davis, M. (1985) · Psychopharmacology · doi:10.1007/bf00432707 · Cited by 52 · see citing works

Antidepressant-Like Effect of Endomorphin-1 and Endomorphin-2 in Mice

Fichna, J., Janecka, A. E., Piestrzeniewicz, M. K., Costentin, J., & do-Rego, J.-C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301149 · Cited by 51 · see citing works

Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test

Chenu, F., Guiard, B. P., Bourin, M., & Gardier, A. M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.011 · Cited by 51 · see citing works

Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments

Simon, N. G., Guillon, C., Fabio, K. M., Heindel, N. D., Lu, S., Miller, M., Ferris, C. F., Brownstein, M., Garippa, C., & KOPPEL, G. A. (2008) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488908784534586 · Cited by 51 · see citing works

Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice

Tanaka, M., & Telegdy, G. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.08.009 · Cited by 50 · see citing works

Neurohypophyseal hormones and brain neurochemistry

Versteeg, D. H. G. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90071-7 · Cited by 50 · see citing works

Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1)

Chawaf, A. A., Xu, K. H., Tan, L. A., Vaccarino, F. J., Lovejoy, D. A., & Rotzinger, S. (2007) · Peptides · doi:10.1016/j.peptides.2007.05.014 · Cited by 49 · see citing works

Corticotropin-releasing factor type-1 receptor antagonists: The next class of antidepressants?

Nielsen, D. M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.003 · Cited by 49 · see citing works

From MIF-1 to endomorphin: The Tyr-MIF-1 family of peptides

Pan, W., & Kastin, A. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.10.006 · Cited by 47 · see citing works

Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats

Goyal, S. N., Kokare, D. M., Ct, C., & Subhedar, N. K. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.004 · Cited by 46 · see citing works

Modulary effects of oxytocin and carbetocin on stress-induced changes in rat behavior in the open-field.

Klenerová, V., Krejčı́, I., Sida, P., Hlinak, Z., & Hynie, S. (2009) · PubMed · Cited by 46 · see citing works

Induction of NGFI-B mRNA following contextual fear conditioning and its blockade by diazepam

Malkani, S., & Rosen, J. B. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00130-3 · Cited by 44 · see citing works

Rapid clinical effectiveness of MIF-I in the treatment of major depressive illness

VELDE, C. D. V. D. (1983) · Peptides · doi:10.1016/0196-9781(83)90136-5 · Cited by 42 · see citing works

CCK B antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze

Wilson, J., Watson, W. P., & Little, H. J. (1998) · Psychopharmacology · doi:10.1007/s002130050601 · Cited by 41 · see citing works

Improvement in major depression after low subcutaneous doses of MIF-1

Ehrensing, R. H., Kastin, A. J., Wurzlow, G. F., Michell, G. F., & Mebane, A. H. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90098-1 · Cited by 41 · see citing works

MIF-I suppresses deprivation-induced fluid consumption in rats

Olson, R. D., Kastin, A. J., Olson, G. A., King, B. M., von Almen, T. K., Berzas, M. C., Ibanez, M. L., & Coy, D. H. (1980) · Peptides · doi:10.1016/0196-9781(80)90014-5 · Cited by 40 · see citing works

The Effects of Psychological Stress on Depression

Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1304150831150507 · Cited by 589 · see citing works

Breaking the loop: Oxytocin as a potential treatment for drug addiction

McGregor, I. S., & Bowen, M. T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.001 · Cited by 268 · see citing works

The Role of Oxytocin in Psychiatric Disorders: A Review of Biological and Therapeutic Research Findings

Cochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0b013e3182a75b7d · Cited by 267 · see citing works

Stress, Endocrine Physiology and Pathophysiology -- Endotext

DeGroot, L. J., Chrousos, G. P., Dungan, K., Grossman, A. B., Jm, H., Koch, C., Korbonits, M., McLachlan, R., New, M., Purnell, J. Q., et al. (2000) · Europe PMC (PubMed Central) · Cited by 260 · see citing works

Comparative Analyses of Zebrafish Anxiety-Like Behavior Using Conflict-Based Novelty Tests

Kysil, E. V., Мешалкина, Д. А., Frick, E. E., Echevarria, D. J., Rosemberg, D. B., Maximino, C., Lima, M. G., de Abreu, M. S., Giacomini, A. C. V. V., Barcellos, L. J. G., et al. (2017) · Zebrafish · doi:10.1089/zeb.2016.1415 · Cited by 257 · see citing works

The endocannabinoid system in anxiety, fear memory and habituation

Ruehle, S., Rey, A. A., Remmers, F., & Lutz, B. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408958 · Cited by 236 · see citing works

Species, sex and individual differences in the vasotocin/vasopressin system: relationship to neurochemical signaling in the social behavior neural network

Albers, H. E. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.07.001 · Cited by 200 · see citing works

The neuroendocrinology of primate maternal behavior

Wendy Saltzman, A., & Dario Maestripieri, A. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.017 · Cited by 150 · see citing works

Behavioural characterisation of chronic unpredictable stress based on ethologically relevant paradigms in rats

Sequeira‐Cordero, A., Salas-Bastos, A., Fornaguera, J., & Brenes, J. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53624-1 · Cited by 140 · see citing works

Oxytocin׳s role in anxiety: A critical appraisal

MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139 · see citing works

Characterization of GABAergic Marker Expression in the Chronic Unpredictable Stress Model of Depression

Banasr, M., Lepack, A., Fee, C., Duric, V., Maldonado-Aviles, J., DiLeone, R., Sibille, E., Duman, R. S., & Sanacora, G. (2017) · Chronic Stress · doi:10.1177/2470547017720459 · Cited by 135 · see citing works

Exploring the role of neuropeptides in depression and anxiety

Rana, T., Behl, T., Sehgal, A., Singh, S., Sharma, N., Abdeen, A., Ibrahim, S. F., Mani, V., Iqbal, M. S., Bhatia, S., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110478 · Cited by 126 · see citing works

Exercise offers anxiolytic potential: A role for stress and brain noradrenergic-galaninergic mechanisms

Sciolino, N. R., & Holmes, P. V. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.06.005 · Cited by 116 · see citing works

Ghrelin alleviates anxiety- and depression-like behaviors induced by chronic unpredictable mild stress in rodents

Huang, H.-J., Zhu, X.-C., Han, Q.-Q., Wang, Y.-L., Yue, N., Wang, J., Yu, R., Li, B., Wu, G.-C., Liu, Q., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.040 · Cited by 114 · see citing works

Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats

Sabihi, S., Durosko, N. E., Dong, S. M., & Leuner, B. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.009 · Cited by 106 · see citing works

The influence of depressive symptomatology and perceived stress on plasma and salivary oxytocin before, during and after a support enhancement intervention

Holt-Lunstad, J., Birmingham, W., & Light, K. C. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.007 · Cited by 103 · see citing works

High plasma nesfatin-1 level in patients with major depressive disorder

Arı, M., Öztürk, O. H., Bez, Y., Oktar, S., & Erduran, D. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.004 · Cited by 105 · see citing works

Oxytocin in the medial prefrontal cortex regulates maternal care, maternal aggression and anxiety during the postpartum period

Sabihi, S., Dong, S. M., Durosko, N. E., & Leuner, B. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00258 · Cited by 101 · see citing works

Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches

Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works

Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice

Christiansen, S. H., Olesen, M. V., Wörtwein, G., & Woldbye, D. P. D. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.044 · Cited by 103 · see citing works

Neuropeptidergic Signaling Partitions Arousal Behaviors in Zebrafish

Woods, I. G., Schoppik, D., Shi, V. J., Zimmerman, S., Coleman, H. A., Greenwood, J. S. F., Soucy, E. R., & Schier, A. F. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3529-13.2014 · Cited by 97 · see citing works

Effects of early life social stress on maternal behavior and neuroendocrinology

Murgatroyd, C., & Nephew, B. C. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.05.020 · Cited by 100 · see citing works

Central administration of ghrelin alters emotional responses in rats: behavioural, electrophysiological and molecular evidence

Hansson, C., Haage, D., Taube, M., Egecioglu, E., Salomé, N., & Dickson, S. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.002 · Cited by 100 · see citing works

PI3K/Akt Signaling Pathway in the Basolateral Amygdala Mediates the Rapid Antidepressant-like Effects of Trefoil Factor 3

Shi, H., Zhu, W., Liu, J., Luo, Y., Si, J., Wang, S., Xue, Y.-X., Ding, Z., Shi, J., & Lü, L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.131 · Cited by 96 · see citing works

Variation in maternal and anxiety-like behavior associated with discrete patterns of oxytocin and vasopressin 1a receptor density in the lateral septum

Curley, J. P., Jensen, C. L., Franks, B., & Champagne, F. A. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.01.013 · Cited by 90 · see citing works

Phylogenetic Analysis of the Teneurins: Conserved Features and Premetazoan Ancestry

Tucker, R. P., Beckmann, J., Leachman, N. T., Schöler, J., & Chiquet‐Ehrismann, R. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr271 · Cited by 91 · see citing works

Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention

Nollet, M., & Leman, S. (2013) · CNS Drugs · doi:10.1007/s40263-013-0064-z · Cited by 89 · see citing works

Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm: Peripheral vs Central Administration

Ayers, L. W., Missig, G., Schulkin, J. A., & Rosen, J. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.138 · Cited by 87 · see citing works

The Role of Clock in Ethanol-Related Behaviors

Ozburn, A. R., Falcón, E., Mukherjee, S., Gillman, A. G., Arey, R. N., Spencer, S. M., & McClung, C. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.138 · Cited by 86 · see citing works

The mechanism of electroacupuncture for depression on basic research: a systematic review

Han, X., Gao, Y., Yin, X., Zhang, Z., Lao, L., Chen, Q., & Xu, S. (2021) · Chinese Medicine · doi:10.1186/s13020-020-00421-y · Cited by 87 · see citing works

Oxytocin in the medial prefrontal cortex attenuates anxiety: Anatomical and receptor specificity and mechanism of action

Sabihi, S., Dong, S. M., Maurer, S., Goodpaster, C. M., & Leuner, B. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.024 · Cited by 84 · see citing works

Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm

Missig, G., Ayers, L. W., Schulkin, J., & Rosen, J. B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.155 · Cited by 79 · see citing works

Hypothalamus and Post-Traumatic Stress Disorder: A Review

Raise‐Abdullahi, P., Meamar, M., Vafaei, A. A., Alizadeh, M., Dadkhah, M., Shafia, S., Ghalandari-Shamami, M., Naderian, R., Samaei, A., & Rashidy‐Pour, A. (2023) · Brain Sciences · doi:10.3390/brainsci13071010 · Cited by 80 · see citing works

Role of 5-HT3 Receptors in the Antidepressant Response

Betry, C., Etiévant, A., Oosterhof, C. A., Ebert, B., Sánchez, C., & Haddjeri, N. (2011) · Pharmaceuticals · doi:10.3390/ph4040603 · Cited by 76 · see citing works

Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

Smith, C. M., Walker, A. W., Hosken, I. T., Chua, B. E., Zhang, C., Haidar, M., & Gundlach, A. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00046 · Cited by 68 · see citing works

Repeated treatment with oxytocin promotes hippocampal cell proliferation, dendritic maturation and affects socio-emotional behavior

Sánchez-Vidaña, D. I., Chan, N.-M. J., Chan, A. H. L., Hui, K. K. Y., Lee, S. Y., Chan, H.-Y., Law, Y. S., Sze, M. Y., Tsui, W.-C. S., Fung, T. K. H., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.005 · Cited by 70 · see citing works

Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety

Morales‐Medina, J. C., Dumont, Y., Benoit, C.-É., Bastianetto, S., Flores, G., Fournier, A., & Quirion, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.030 · Cited by 68 · see citing works

May oxytocin be a trait marker for bipolar disorder?

Turan, T., Uysal, C., Asdemir, A., & Kılıç, E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.07.017 · Cited by 66 · see citing works

Behavioral effect of neuropeptides related to feeding regulation in fish

Matsuda, K., Kang, K. S., Sakashita, A., Yahashi, S., & Vaudry, H. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05884.x · Cited by 65 · see citing works

Differential Activity by Polymorphic Variants of a Remote Enhancer that Supports Galanin Expression in the Hypothalamus and Amygdala: Implications for Obesity, Depression and Alcoholism

Davidson, S., Lear, M., Shanley, L. J., Hing, B. W. Q., Baizan-Edge, A., Herwig, A., Quinn, J. P., Breen, G. D., McGuffin, P., Starkey, A. J., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.93 · Cited by 65 · see citing works

Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: Dissociation between anxiety, locomotion and non-emotional memory behavior

Lach, G., & de Lima, T. C. M. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.005 · Cited by 64 · see citing works

Relaxin’ the brain: a case for targeting the nucleus incertus network and relaxin‐3/RXFP3 system in neuropsychiatric disorders

Kumar, J. R., Rajkumar, R., Jayakody, T., Marwari, S., Hóng, J., Ma, S., Gundlach, A. L., Lai, M. K. P., & Dawe, G. S. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13564 · Cited by 62 · see citing works

Neurobiological consequences of juvenile stress: A GABAergic perspective on risk and resilience

Albrecht, A., Müller, I., Ardi, Z., Çalışkan, G., Gruber, D., Ivens, S., Segal, M., Behr, J., Heinemann, U., Stork, O., et al. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.005 · Cited by 63 · see citing works

Predictable maternal separation confers adult stress resilience via the medial prefrontal cortex oxytocin signaling pathway in rats

Shi, D.-D., Zhang, Y.-D., Ren, Y.-Y., Peng, S.-Y., Yuan, T.-F., & Wang, Z. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01293-w · Cited by 63 · see citing works

Sex-specific regulation of NUCB2/nesfatin-1: Differential implication in anxiety in obese men and women

Hofmann, T., Elbelt, U., Ahnis, A., Rose, M., Klapp, B. F., & Stengel, A. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.014 · Cited by 63 · see citing works

MOLECULAR EVOLUTION OF GPCRS: CRH/CRH receptors

Lovejoy, D. A., Chang, B. S. W., Lovejoy, N. R., & del Castillo, J. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0238 · Cited by 63 · see citing works

An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors

Arey, R. N., Enwright, J. F., Spencer, S. M., Falcon, E., Ozburn, A. R., Ghose, S., Tamminga, C., & McClung, C. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.12 · Cited by 62 · see citing works

On the Teneurin track: a new synaptic organization molecule emerges

Mosca, T. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00204 · Cited by 60 · see citing works

Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice

Del Boca, C., Lutz, P. E., Le Merrer, J., Koebel, P., & Kieffer, B. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.022 · Cited by 59 · see citing works

Identification of the novel bioactive peptides dRYamide-1 and dRYamide-2, ligands for a neuropeptide Y-like receptor in Drosophila

Ida, T., Takahashi, T., Tominaga, H., Sato, T., Kume, K., Ozaki, M., Hiraguchi, T., Maeda, T., Shiotani, H., Terajima, S., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.081 · Cited by 58 · see citing works

Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder

Gunay, H., Tutuncu, R., Aydın, S., Dağ, E., & Abaslı, D. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.007 · Cited by 58 · see citing works

Anxiety and Depression: What Do We Know of Neuropeptides?

Kupcová, I., Danišovič, Ľ., Grgac, I., & Harsányi, Š. (2022) · Behavioral Sciences · doi:10.3390/bs12080262 · Cited by 57 · see citing works

Impacts of early intervention with fluoxetine following early neonatal immune activation on depression-like behaviors and body weight in mice

Doosti, M.-H., Bakhtiari, A., Zare, P., Amani, M., Zolbanin, N. M., Babri, S., & Salari, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.003 · Cited by 56 · see citing works

Relaxin-3-Deficient Mice Showed Slight Alteration in Anxiety-Related Behavior

Watanabe, Y., Tsujimura, A., Takao, K., Nishi, K., Ito, Y., Yasuhara, Y., Nakatomi, Y., Yokoyama, C., Fukui, K., Miyakawa, T., et al. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00050 · Cited by 56 · see citing works

PLASMA OXYTOCIN CONCENTRATION AND DEPRESSIVE SYMPTOMS: A REVIEW OF CURRENT EVIDENCE AND DIRECTIONS FOR FUTURE RESEARCH

Massey, S. H., Backes, K. A., & Schuette, S. (2016) · Depression and Anxiety · doi:10.1002/da.22467 · Cited by 53 · see citing works

Central and peripheral effects of ghrelin on energy balance, food intake and lipid metabolism in teleost fish

Kang, K. S., Yahashi, S., & Matsuda, K. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.006 · Cited by 47 · see citing works

Meta-analytic review of the effects of a single dose of intranasal oxytocin on threat processing in humans

Leppanen, J., Ng, K. W., Kim, Y.-R., Tchanturia, K., & Treasure, J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.041 · Cited by 45 · see citing works

Synthesis of an MIF-1 analogue containing enantiopure ( S )-α-trifluoromethyl-proline and biological evaluation on nociception

Jlalia, I., Lensen, N., Chaume, G., Dzhambazova, E. B., Astasidi, L., Tafradjiiska-Hadjiolova, R. K., Bocheva, A. I., & Brigaud, T. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.041 · Cited by 45 · see citing works

The role of orexin in post-stroke inflammation, cognitive decline, and depression

Song, J., Kim, E., Kim, C. H., Song, H., & Lee, J. E. (2015) · Molecular Brain · doi:10.1186/s13041-015-0106-1 · Cited by 46 · see citing works

Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects

Naja, W., & Aoun, M. P. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0819-1 · Cited by 40 · see citing works

Investigating the potential role of TRPA 1 in locomotion and cardiovascular control during hypertension

Bodkin, J. V., Thakore, P., Aubdool, A. A., Liang, L., Fernandes, E. S., Nandi, M., Spina, D., Clark, J., Aaronson, P. I., Shattock, M. J., et al. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.52 · Cited by 41 · see citing works

Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor

Wu, X., Hsuchou, H., Kastin, A. J., He, Y., Khan, R. S., Stone, K. P., Cash, M. S., & Pan, W. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.017 · Cited by 41 · see citing works

Diet-Regulated Anxiety

Murphy, M., & Mercer, J. G. (2013) · International Journal of Endocrinology · doi:10.1155/2013/701967 · Cited by 40 · see citing works

C-terminal processing of the teneurin proteins: Independent actions of a teneurin C-terminal associated peptide in hippocampal cells

Chand, D. S., Casatti, C. A., de Lannoy, L., Song, L., Kollara, A., Baršytė-Lovejoy, D., Brown, T. J., & Lovejoy, D. A. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.09.006 · Cited by 40 · see citing works

Social rank‐dependent expression of arginine vasotocin in distinct preoptic regions in male Oryzias latipes

Kagawa, N. (2012) · Journal of Fish Biology · doi:10.1111/j.1095-8649.2012.03490.x · Cited by 39 · see citing works

Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications

Iovino, M., Messana, T., Tortora, A., Giusti, C., Lisco, G., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200520093730 · Cited by 39 · see citing works

Effects of electroconvulsive seizures on depression-related behavior, memory and neurochemical changes in Wistar and Wistar–Kyoto rats

Kyeremanteng, C., MacKay, J. C., James, J. S., Kent, P., Cayer, C., Anisman, H., & Merali, Z. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.012 · Cited by 37 · see citing works

Substance P receptor antagonist in lateral habenula improves rat depression-like behavior

Yang, L.-M., Yu, L., Jin, H., & Zhao, H. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.10.007 · Cited by 36 · see citing works

The Role of the PACAP Signaling System in Depression

Pinhasov, A., Nesher, E., Gross, M., Turgeman, G., Kreinin, A., & Yadid, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795589328 · Cited by 37 · see citing works

Behavioral training and predisposed coping strategies interact to influence resilience in male Long-Evans rats: Implications for depression

Bardi, M., Rhone, A. P., Franssen, C. L., Hampton, J. E., Shea, E. A., Hyer, M. M., Huber, J., & Lambert, K. G. (2012) · Stress · doi:10.3109/10253890.2011.623739 · Cited by 37 · see citing works

NPY Intraperitoneal Injections Produce Antidepressant‐Like Effects and Downregulate BDNF in the Rat Hypothalamus

Gelfo, F., Tirassa, P., Bartolo, P. D., Croce, N., Bernardini, S., Caltagirone, C., Petrosini, L., & Angelucci, F. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00314.x · Cited by 36 · see citing works

Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions

Narváez, M., Millón, C., Borroto‐Escuela, D. O., Flores‐Burgess, A., Santín, L. J., Parrado, C., Gago, B., Puigcerver, A., Fuxé, K., Narváez, J. Á., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0788-7 · Cited by 36 · see citing works

The Role of Neuropeptide Y in the Nucleus Accumbens

Tanaka, M., Yamada, S., & Watanabe, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147287 · Cited by 35 · see citing works

Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice

Antunes, M. S., Ruff, J. R., Janner, D. E., Piêgas, M. B., de Brito, M. L. O., Rocha, K. M. A., de Gomes, M. G., Goes, A. T. R., Souza, L. C., Donato, F., et al. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.018 · Cited by 35 · see citing works

Inhibition of Maternal Behaviour by Central Infusion of Corticotrophin‐Releasing Hormone in Marmoset Monkeys

Wendy Saltzman, A., Boettcher, C., Post, J., & Abbott, D. H. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02153.x · Cited by 33 · see citing works

Anticonvulsant neuropeptides as drug leads for neurological diseases

Robertson, C. R., Flynn, S. P., White, H. S., & Bulaj, G. W. (2011) · Natural Product Reports · doi:10.1039/c0np00048e · Cited by 33 · see citing works

Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout mice

Pastor, R., Reed, C. L., Burkhart‐Kasch, S., Li, N., Sharpe, A. L., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2284-6 · Cited by 33 · see citing works

Unpredictable chronic mild stress differentially impairs social and contextual discrimination learning in two inbred mouse strains

Boxelaere, M. V., Clements, J., Callaerts, P., D’Hooge, R., & Callaerts‐Vegh, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188537 · Cited by 31 · see citing works

Orexin A enhances locomotor activity and induces anxiogenic-like action in the goldfish, Carassius auratus

Nakamachi, T., Shibata, H., Sakashita, A., Iinuma, N., Wada, K., Konno, N., & Matsuda, K. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.06.004 · Cited by 31 · see citing works

Urocortin 2 modulates aspects of social behaviour in mice

Breu, J., Touma, C., Hölter, S. M., Knapman, A., Wurst, W., & Deussing, J. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.031 · Cited by 30 · see citing works

Neuropeptide F neurons modulate sugar reward during associative olfactory learning of Drosophila larvae

Rohwedder, A., Selcho, M., Chassot, B., & Thum, A. S. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23873 · Cited by 30 · see citing works

Effects of environmental manipulations in genetically targeted animal models of affective disorders

Renoir, T., Pang, T. Y., & Hannan, A. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.003 · Cited by 31 · see citing works

Assessing the serum concentration levels of NT-4/5, GPX-1, TNF-α, and l -arginine as biomediators of depression severity in first depressive episode patients with and without posttraumatic stress disorder

Ogłodek, E. A., Just, M. J., Szromek, A. R., & Araszkiewicz, A. S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.04.013 · Cited by 29 · see citing works

The octadecaneuropeptide exerts an anxiogenic-like action in goldfish

Matsuda, K., Wada, K., Azuma, M., Leprince, J., Tonon, M., Sakashita, A., Maruyama, K., Uchiyama, M., & Vaudry, H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.058 · Cited by 29 · see citing works

Neuropeptide Trefoil factor 3 improves learning and retention of novel object recognition memory in mice

Shi, H., Yin, X., Song, L., Guo, Q., & Luo, X.-H. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.051 · Cited by 29 · see citing works

Comparison of Aggressive Behaviors Between Two Wild Populations of Japanese Medaka,Oryzias latipesandO. sakaizumii

Kagawa, N. (2014) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.31.116 · Cited by 29 · see citing works

Effects of Chronic Central Arginine Vasopressin (AVP) on Maternal Behavior in Chronically Stressed Rat Dams

Coverdill, A. J., McCarthy, M., Bridges, R. S., & Nephew, B. C. (2012) · Brain Sciences · doi:10.3390/brainsci2040589 · Cited by 27 · see citing works

Effects of neural androgen receptor disruption on aggressive behavior, arginine vasopressin and galanin systems in the bed nucleus of stria terminalis and lateral septum

Marie-Luce, C., Raskin, K., Bolborea, M., Monin, M., Picot, M., & Mhaouty‐Kodja, S. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.03.031 · Cited by 27 · see citing works

On the Role of Cholecystokinin (CCK) in Fear and Anxiety: A Review and Research Proposal

Crespi, F. (2019) · Journal of Human Psychology · doi:10.14302/issn.2644-1101.jhp-19-2766 · Cited by 26 · see citing works

Circadian Modulation of Anxiety: A Role for Somatostatin in the Amygdala

Albrecht, A., Thiere, M., Bergado-Acosta, J. R., Poranzke, J., Müller, B., & Stork, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084668 · Cited by 26 · see citing works

The Neurokinin-1 Receptor in Addictive Processes

Schank, J. R. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210799 · Cited by 26 · see citing works

The Effects of Ghrelin on Energy Balance and Psychomotor Activity in a Goldfish Model: An Overview

Kang, K. S., Yahashi, S., & Matsuda, K. (2011) · International Journal of Peptides · doi:10.1155/2011/171034 · Cited by 26 · see citing works

Plasma Nesfatin-1 Level May Be Associated with Disease Severity in Patients with Panic Disorder

Bez, Y., Arı, M., Öztürk, O. H., Oktar, S., Can, Y., & Söğüt, S. (2010) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2010.11790674 · Cited by 26 · see citing works

Prenatal and gestational cocaine exposure: Effects on the oxytocin system and social behavior with implications for addiction

Williams, S. K., & Johns, J. M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.004 · Cited by 26 · see citing works

Repeated intravenous administrations of teneurin-C terminal associated peptide (TCAP)-1 attenuates reinstatement of cocaine seeking by corticotropin-releasing factor (CRF) in rats

Erb, S. M., McPhee, M. D., Brown, Z. J., Kupferschmidt, D. A., Song, L., & Lovejoy, D. A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.013 · Cited by 24 · see citing works

Nose to brain delivery of escitalopram-loaded nano-structured lipid carriers thermosensitive gel: Formulation, physiochemical, pharmacokinetic and pharmacodynamics evaluation

Jawad, M., Shafique, U., Din, F. U., Butt, A., Khan, S., Khan, G. M., Alamri, A. H., Lahiq, A. A., Alsharif, S. T., & Almerai, K. S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105800 · Cited by 23 · see citing works

Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like behaviors in rats based on a microarray and peptidome analysis

Nakazawa, C. M., Shikata, K., Uesugi, M., Katayama, H., Aoshima, K., Tahara, K., Takahashi, E., Hida, T., Shibata, H., Ogura, H., et al. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.756895 · Cited by 23 · see citing works

Ovine corticotropin-releasing hormone (oCRH) exerts an anxiogenic-like action in the goldfish, Carassius auratus

Matsuda, K., Hagiwara, Y., Shibata, H., Sakashita, A., & Wada, K. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.01.001 · Cited by 23 · see citing works

The Role of Endogenous Oxytocin in Anxiolysis: Structural and Functional Correlates

Lancaster, K., Goldbeck, L., Pournajafi‐Nazarloo, H., Connelly, J. J., Carter, C. S., & Morris, J. P. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.10.003 · Cited by 23 · see citing works

DNA methylation ofOXTRis associated with parasympathetic nervous system activity and amygdala morphology

Lancaster, K., Goldbeck, L., Puglia, M. H., Morris, J. P., & Connelly, J. J. (2018) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsy086 · Cited by 23 · see citing works

Neurohypophyseal hormones and brain neurochemistry

Versteeg, D. H. G. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90071-7 · Cited by 50 · see citing works

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

Holmes, A., Heilig, M. A., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 401 · see citing works

Role of neuropeptides in anxiety, stress, and depression: From animals to humans

Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 327 · see citing works

Neuropeptides as Therapeutic Targets in Anxiety Disorders

Lin, E.-J. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803530871 · Cited by 28 · see citing works

Exploring the role of neuropeptides in depression and anxiety

Rana, T., Behl, T., Sehgal, A., Singh, S., Sharma, N., Abdeen, A., Ibrahim, S. F., Mani, V., Iqbal, M. S., Bhatia, S., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110478 · Cited by 126 · see citing works